Alcaftadine-d3

Intermediate in the production of labelled Mitoxantrone.

A novel inhibitor of antiapoptotic BCL-2 proteins; a new promising anticancer drug candidate.

A selective inhibitor of BCL-2, in small cell lung cancer. ABT-737 induced dramatic regressions in tumors derived from some SCLC cell lines.

It is a Labelled Aldicarb Sulfoxide. Aldicarb Sulfoxide is an analog of Aldicarb detected in agricultural products as pesticide residue.

Intermediate in the preparation of labelled Cycloserine.

A novel labelled metabolite of Perchloroethene (PER) in humans after inhalation. It is an important biomarker for the glutathione dependent biotransformation of PER.

Component used in the preparation of Cyanine dyes.

trans-Abacavir-d4 Hydrochloride is deuterium labeled trans-Abacavir Dihydrochloride, which is an impurity of Abacavir. Abacavir is a carbocyclic 2'-deoxyguanosine nucleoside reverse transcriptase inhibitor and an anti-HIV drug.

Labelled antilipemic.

Isotope labelled 2-Acetamido-5-chlorobenzophenone is an intermediate in the synthesis of isotope labelled Desmethyl Diazepam, the primary metabolite of Diazepam.

Molecular formula: C19H21NOS.C2H2O4Molecular weight: 401.48

Molecular formula: C22H23N3O4SMolecular weight: 425.5

Clearsynth Labs Limited is a technology-based, research-driven, innovation-led enterprise specializing in deuterium chemistry and stable isotopes. Headquartered in Mumbai, with an R&D center in Hyderabad and a CDMO facility in Karnataka, alongside operations in Canada and the USA, we deliver solutions from milligram-scale R&D to multi-ton manufacturing. Our expertise spans deuterated APIs, intermediates, impurities, and reference standards. Backed by strong IP and 350+ scientists, we partner with innovators and generics across CDMO and CMO segments, committed to precision, quality, and advancing next-generation isotopic solutions for global pharmaceutical needs.